BerandaABDX • LON
add
Abingdon Health PLC
Tutup sebelumnya
GBXÂ 8,00
Rentang hari
GBXÂ 7,86 - GBXÂ 8,48
Rentang tahun
GBXÂ 5,10 - GBXÂ 9,00
Kapitalisasi pasar
20,71Â jt GBP
Volume Rata-Rata
222,20Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
LON
Berita pasar
Investing.com Indonesia
13 jam yang lalu
Evogene terima peringatan delisting Nasdaq karena harga saham
1,76%
3,36%
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (GBP) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,12Â jt | 36,94% |
Biaya operasional | 1,85Â jt | -3,48% |
Penghasilan bersih | -1,17Â jt | 6,82% |
Margin laba bersih | -55,44 | 31,96% |
Penghasilan per saham | — | — |
EBITDA | -964,00Â rb | 18,79% |
Tarif pajak efektif | -2,22% | — |
Neraca
Total aset
Total liabilitas
| (GBP) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,71Â jt | 0,98% |
Total aset | 10,55Â jt | 7,44% |
Total liabilitas | 4,25Â jt | 25,02% |
Total ekuitas | 6,30 jt | — |
Saham yang beredar | 433,39 jt | — |
Harga terhadap nilai buku | 8,00 | — |
Tingkat pengembalian aset | -27,04% | — |
Tingkat pengembalian modal | -39,37% | — |
Arus Kas
Perubahan kas bersih
| (GBP) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -1,17Â jt | 6,82% |
Kas dari operasi | -642,50Â rb | 41,43% |
Kas dari investasi | -5,50Â rb | 99,04% |
Kas dari pembiayaan | 1,55Â jt | -44,39% |
Perubahan kas bersih | 894,50Â rb | -19,81% |
Arus kas bebas | -484,12Â rb | 28,31% |
Tentang
Abingdon Health is a leading international developer, manufacturer and distributor of lateral flow assay diagnostic tests, sometimes called rapid tests, lateral flow immunoassays, lateral flow tests or quick tests. Since its formation in 2008, Abingdon Health has developed and manufactured lateral flow rapid tests across multiple industries. Headquartered in York, with sites in Doncaster and Madison, USA. Wikipedia
CEO
Didirikan
1 Jan 2008
Situs
Karyawan
129
